RYTM
RYTM
US76243J1051
Rhythm Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 189.757.000 130.126.000
45.8%
Cost of Revenue 19.492.000 13.368.000
45.8%
Gross Profit 170.265.000 116.758.000
45.8%
362.281.000 382.261.000
5.2%
Operating Income -192.016.000 -265.503.000
27.7%
Pretax Income -196.042.000 -260.256.000
24.7%
Net Income Common Stockholders -201.917.000 -264.572.000
23.7%
-- --
--
-- --
--
ende